Literature DB >> 24622366

Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study.

Lieza G Exalto1, Geert Jan Biessels2, Andrew J Karter3, Elbert S Huang4, Wayne J Katon5, Jerome R Minkoff6, Rachel A Whitmer7.   

Abstract

BACKGROUND: Although patients with type 2 diabetes are twice as likely to develop dementia as those without this disease, prediction of who has the highest future risk is difficult. We therefore created and validated a practical summary risk score that can be used to provide an estimate of the 10 year dementia risk for individuals with type 2 diabetes.
METHODS: Using data from two longitudinal cohorts of patients with type 2 diabetes (aged ≥60 years) with 10 years of follow-up, we created (n=29,961) and validated (n=2413) the risk score. We built our prediction model by evaluating 45 candidate predictors using Cox proportional hazard models and developed a point system for the risk score based on the size of the predictor's β coefficient. Model prediction was tested by discrimination and calibration methods. Dementia risk per sum score was calculated with Kaplan-Meier estimates.
FINDINGS: Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic events, depression, age, and education were most strongly predictive of dementia and constituted the risk score (C statistic 0·736 for creation cohort and 0·746 for validation cohort). The dementia risk was 5·3% (95% CI 4·2-6·3) for the lowest score (-1) and 73·3% (64·8-81·8) for the highest (12-19) sum scores.
INTERPRETATION: To the best of our knowledge, this is the first risk score for the prediction of 10 year dementia risk in patients with type 2 diabetes mellitus. The risk score can be used to increase vigilance for cognitive deterioration and for selection of high-risk patients for participation in clinical trials. FUNDING: Kaiser Permanente Community Benefit, National Institute of Health, Utrecht University, ZonMw, and Fulbright.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24622366      PMCID: PMC4429783          DOI: 10.1016/S2213-8587(13)70048-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  30 in total

1.  Intensive glucose lowering and cognition in type 2 diabetes.

Authors:  Geert Jan Biessels
Journal:  Lancet Neurol       Date:  2011-09-28       Impact factor: 44.182

2.  Risk factors for dementia in patients over 65 with diabetes.

Authors:  Niraj M Parikh; Robert O Morgan; Mark E Kunik; Hua Chen; Rajender R Aparasu; Ravi K Yadav; Paul E Schulz; Michael L Johnson
Journal:  Int J Geriatr Psychiatry       Date:  2010-10-04       Impact factor: 3.485

3.  Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population.

Authors:  Howard H Moffet; Nancy Adler; Dean Schillinger; Ameena T Ahmed; Barbara Laraia; Joe V Selby; Romain Neugebauer; Jennifer Y Liu; Melissa M Parker; Margaret Warton; Andrew J Karter
Journal:  Int J Epidemiol       Date:  2008-03-07       Impact factor: 7.196

4.  Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets.

Authors:  Prabasaj Paul; Michael L Pennell; Stanley Lemeshow
Journal:  Stat Med       Date:  2012-07-26       Impact factor: 2.373

5.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

6.  Prediction of dementia in primary care patients.

Authors:  Frank Jessen; Birgitt Wiese; Horst Bickel; Sandra Eiffländer-Gorfer; Angela Fuchs; Hanna Kaduszkiewicz; Mirjam Köhler; Tobias Luck; Edelgard Mösch; Michael Pentzek; Steffi G Riedel-Heller; Michael Wagner; Siegfried Weyerer; Wolfgang Maier; Hendrik van den Bussche
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

7.  Predicting risk of dementia in older adults: The late-life dementia risk index.

Authors:  D E Barnes; K E Covinsky; R A Whitmer; L H Kuller; O L Lopez; K Yaffe
Journal:  Neurology       Date:  2009-05-13       Impact factor: 9.910

8.  Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Authors:  Fumiko Irie; Annette L Fitzpatrick; Oscar L Lopez; Lewis H Kuller; Rita Peila; Anne B Newman; Lenore J Launer
Journal:  Arch Neurol       Date:  2008-01

9.  Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study.

Authors:  Wayne J Katon; Elizabeth H B Lin; Lisa H Williams; Paul Ciechanowski; Susan R Heckbert; Evette Ludman; Carolyn Rutter; Paul K Crane; Malia Oliver; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2010-01-28       Impact factor: 5.128

10.  Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10).

Authors:  Helen L Lutgers; Esther G Gerrits; Wim J Sluiter; Lielith J Ubink-Veltmaat; Gijs W D Landman; Thera P Links; Reinold O B Gans; Andries J Smit; Henk J G Bilo
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more
  66 in total

1.  Inequalities in dementia incidence between six racial and ethnic groups over 14 years.

Authors:  Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimers Dement       Date:  2016-02-11       Impact factor: 21.566

2.  Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study.

Authors:  Wayne Katon; Henrik Sondergaard Pedersen; Anette Riisgaard Ribe; Morten Fenger-Grøn; Dimitry Davydow; Frans Boch Waldorff; Mogens Vestergaard
Journal:  JAMA Psychiatry       Date:  2015-06       Impact factor: 21.596

3.  Heterogeneity in 14-year Dementia Incidence Between Asian American Subgroups.

Authors:  Elizabeth R Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jul-Sep       Impact factor: 2.703

Review 4.  [Diabetes and the central nervous system].

Authors:  F Erbguth
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

Review 5.  Diabetes and cognition.

Authors:  Elizabeth Rose Mayeda; Rachel A Whitmer; Kristine Yaffe
Journal:  Clin Geriatr Med       Date:  2014-11-15       Impact factor: 3.076

Review 6.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

Review 7.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

Authors:  Geert Jan Biessels; Florin Despa
Journal:  Nat Rev Endocrinol       Date:  2018-10       Impact factor: 43.330

8.  GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis.

Authors:  Mo Wang; Yu Li; Lulu Lin; Guijun Song; Teng Deng
Journal:  Mol Neurobiol       Date:  2015-01-30       Impact factor: 5.590

9.  Association Between Birth in a High Stroke Mortality State, Race, and Risk of Dementia.

Authors:  Paola Gilsanz; Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

10.  Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.

Authors:  Cecilia S Lee; Eric B Larson; Laura E Gibbons; Aaron Y Lee; Susan M McCurry; James D Bowen; Wayne C McCormick; Paul K Crane
Journal:  Alzheimers Dement       Date:  2018-08-08       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.